Health insurance to cover Afinitor

Published: 2011-07-19 06:57:00

Updated: 2011-07-19 06:57:00

The negotiation ended Friday after a compromise was reached between the National Health Insurance Corp. and Novartis Korea on the insurance price of Afinitor (everolimus), a cancer drug to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder.

The insurance price of Afinitor was agreed to set at 94,000 won following a ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.